CHINA Sinovac applies for marketing approval of COVID-19 vaccine in China

CHINA

Sinovac applies for marketing approval of COVID-19 vaccine in China

CGTN

19:29, February 05, 2021

COVID-19 vaccines developed by China's Sinovac. (Photo: CFP)

China's Sinovac Biotech had applied for conditional marketing authorization of its COVID-19 vaccine in the country on Wednesday, the company said Friday.

Data from a late-stage trial in Turkey showed the two-dose vaccine to be 91.25 percent effective, Sinovac said. In Brazil, the vaccine trial results showed a 50.65 percent efficacy, while it is 100 percent effective in preventing severe or death cases.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue